Methods for Diagnosing and Treating Vestibular Schwannoma

ANTI-DRUG ANTIBODY ASSAYS

SIGNATURE OF TL1A (TNFSF15) SIGNALING PATHWAY

SIGNATURES AND DETERMINANTS FOR DIAGNOSING INFECTIONS AND METHODS OF USE THEREOF

METHOD AND SYSTEM FOR MEASURING CELL-MEDIATED IMMUNITY TO ADENO-ASSOCIATED-VIRUS INFECTION

PATIENT SELECTION METHODS AND KITS FOR THERAPIES TARGETING TL1A

NANOBODY TARGETING BCMA AND APPLICATION THEREOF

METHOD FOR PREDICTING THE FERTILITY POTENTIAL OF A FEMALE SUBJECT

USES OF CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL THERAPIES IN COMBINATION WITH INHIBITORS OF INFLAMMATION-RELATED SOLUBLE FACTORS

METHODS AND COMPOSITIONS FOR PREVENTING AND TREATING A CANCER

METHODS OF DIAGNOSING AND TREATING LUPUS

METHODS AND KITS FOR DIAGNOSING MILD COGNITIVE IMPAIRMENT

Signature of TL1A (TNFSF15) signaling pathway

METHODS OF RISK ASSESSMENT AND DISEASE CLASSIFICATION

Signatures and determinants for diagnosing infections and methods of use thereof

Anti-idiotype antibodies targeting anti-CD70 chimeric antigen receptor

ANTI-CD70 ANTIBODIES AND USES THEREOF

Anti-TrkB agonist antibodies binding to D1 domain of TrkB

Methods of prognosis and treatment

LEVELS OF BCMA PROTEIN EXPRESSION ON B CELLS AND USE IN DIAGNOSTIC METHODS OF TREATING SYSTEMIC LUPUS ERYTHEMATOSUS

RANKL-specific agent for treating metastatic disease

METHOD FOR MEASURING SYSTEMIC CHRONIC INFLAMMAGING

DENDRITIC CELL POTENCY ASSAY

CD153 AND/OR CD30 IN INFECTION

Citrullinated peptides that bind to types of MHC class II and their use on diagnosis and treatment

Signature of TL1A (TNFSF15) signaling pathway

Signatures and determinants for diagnosing infections and methods of use thereof

Anti-TrkB agonist antibodies binding to D5 domain of TrkB and methods of promoting neuronal survival in motor neuron injury, stroke or glaucoma

TRAIL-BASED ENCEPHALITIS DIFFERENTIATION DIAGNOSIS METHOD AND THE APPARATUS FOR THE SAME

Compositions and methods for treating chemosensory dysfunction

Methods of risk assessment and disease classification for appendicitis

METHODS OF DIAGNOSING AND TREATING LUPUS

Polypeptides and uses thereof for reducing CD95-mediated cell motility

Signatures and determinants for diagnosing infections in non-human subjects and methods of use thereof

MIC-1 receptor and uses thereof

Signatures and determinants for diagnosing infections and methods of use thereof

Tumor necrosis factor 1B (TNF-1B) mutants and methods of use thereof to screen for candidate therapeutic compounds

Methods and compositions for obtaining a tuberculosis assessment in a subject

Ligand

RANKL-specific agent for treating metastatic disease

BIOMARKERS PREDICTIVE OF LUPUS PROGRESSION AND USES THEREOF

SIGNATURES AND DETERMINANTS FOR DIAGNOSING INFECTIONS IN NON-HUMAN SUBJECTS AND METHODS OF USE THEREOF

BREAST CANCER DIAGNOSTICS USING RANKL AND OPG

Method for identifying and obtaining activated T-cells that have a demethylated Foxp3 TSDR region

Diagnostic anti-CD95L antibody

Polypeptides and uses thereof for reducing CD95-mediated cell motility

METHODS AND COMPOSITIONS FOR IMMUNE DIS-INHIBITION

Signatures and determinants for diagnosing infections and methods of use thereof

April variants

Signature of TL1A (TNFSF15) signaling pathway

CD70-BINDING PEPTIDES AND METHOD, PROCESS AND USE RELATING THERETO

Method of screening for a compound for inhibitory activity of FN14-tweak interaction

Complexes of types of MHC class II that bind to collagen type II peptides and their use on diagnosis and treatment

METHOD OF DIAGNOSING CANCER

Anti-ectodysplasin antibodies

BIOMARKERS PREDICTIVE OF THERAPEUTIC RESPONSIVENESS TO IFNB AND USES THEREOF

Method of predicting survival time in myocardial infarction patients by measuring BAFF levels

Detection and Treatment of Pancreatic, Ovarian and Other CD70 Positive Cancers

Methods for Predicting and Preventing Metastasis in Triple Negative Breast Cancers

BIOMARKERS OF AUTOIMMUNE AND/OR CHRONIC DISEASES ASSOCIATED WITH JOINT INFLAMMATION

Compostions and methods for treating chemosensory dysfunction

METHODS OF PROGNOSTICATING AND TREATING CANCER

Use of a panel of urinary cytokines to predict response to BCG therapy for bladder cancer

Inhibitors of the CD95 signaling pathway for treatment of MDS

BIOMARKERS FOR LOWER URINARY TRACT SYMPTOMS (LUTS)

Signatures and determinants for diagnosing infections and methods of use thereof

PULMONARY HYPERTENSION

BIMER OR AN OLIGOMER OF A DIMER, TRIMER, QUADROMER OR PENTAMER OF RECOMBINANT FUSION PROTEINS

Soluble CD27 (sCD27) and the use thereof

Levels of BCMA protein expression on B cells and use in methods of treating systemic lupus erythematosus

Levels of BLyS/APRIL heterotrimers in serum and use in diagnostic methods

BIOMARKERS PREDICTIVE OF THERAPEUTIC RESPONSIVENESS TO IFNB AND USES THEREOF

METHOD FOR THE QUANTITATIVE AND QUALITATIVE CHARACTERIZATION OF ANTIGEN-SPECIFIC T CELLS RECOGNIZING A SPECIFIC ANTIGEN

Diagnostic and Therapeutic Uses for B Cell Maturation Antigen

BIOMARKERS FOR IAP INHIBITOR COMPOUNDS

PREDICTION OF NON-FATAL AND FATAL ATHEROTHROMBOTIC EVENTS

Methods and kits for the differential diagnosis of Alzheimer's disease versus frontotemporal dementia and for the diagnosis of frontotemporal dementia, comprising FAS-L and CK 18 as biomarkers

BIMER OR AN OLIGOMER OF A DIMER, TRIMER, QUADROMER OR PENTAMER OF RECOMBINANT FUSION PROTEINS

Detection and treatment of pancreatic, ovarian and other cancers

Inducer of chondrocyte proliferation and differentiation

Train-R: A Cysteine Rich Member of the TNF-Receptor Family

Method for the identification and separation of non-regulatory T-cells from a mixture of regulatory T-cells

TAJ in Neuronal Function

Biomarkers of Multiple Sclerosis

Methods of decreasing tumor volume and reducing tumor burden using TNF-receptor-coupling agents

Methods for detection of biological substances

Osteopenia animal model

Method for restoring dendritic cell populations

LEVELS OF BCMA PROTEIN EXPRESSION ON B CELLS AND USE IN DIAGNOSTIC METHODS

Levels of APRIL in serum and use in diagnostic methods

LEVELS OF BLyS/APRIL HETEROTRIMERS IN SERUM AND USE IN DIAGNOSTIC METHODS

Semi-quantitative immunochromatographic device and method for the determination of HIV/AIDS immune-status via measurement of soluble CD40 Ligand/CD154, A CD4+ T cell equivalent and the simultaneous detection of HIV infection via HIV antibody detection

Detection of inflammatory disease and composition for prevention or treatment of inflammatory disease

Methods for diagnosis and treatment of epithelial-derived cancers

Semi-quantitative immunochromatographic device and method for the determination of HIV/AIDS immune-status via measurement of soluble CD40 ligand/CD 154, A CD4+T cell equivalent

BIMER OR AN OLIGOMER OF A DIMER, TRIMER, QUATROMER OR PENTAMER OF RECOMBINANT FUSION PROTEINS

Methods of monitoring the efficacy of anti-CD40 antibodies in treating a subject for a CD40-expressing cancer

Antibodies to train R: a cysteine-rich member of the TNF-receptor family, and methods of treating tumors expressing said receptor

TREATMENT OF RHEUMATOID ARTHRITIS WITH SOLUBLE FAS-LIGAND CROSS-LINKERS

Receptor coupling agents and compositions thereof

Method for identifying type-1 interferon responsive ms patients by determining trail expression

TRAIN-R: a cysteine-rich member of the TNF-receptor family

Methods of designing and producing novel compounds having improved binding affinity for CD154 or other trimeric proteins

Methods for detecting and isolating antigen-specific T lymphocytes with CD40/C154 inhibitors

Agonists and antagonists of ryzn for the treatment of metabolic disorders

Methods of promoting neurite outgrowth with soluble TAJ polypeptides

Modulation of an innate immune response by altering TRIAL-R signaling

Promotion or inhibition of angiogenesis and cardiovascularization by tumor necrosis factor ligand/receptor homologs

Treatment of rheumatoid arthritis with soluble Fas-ligand cross-linkers

Methods for diagnosis and treatment of epithelial-derived cancers